news
Articles
How Clinical Validation Is Reshaping Urology Device Adoption - A Turning Point for Innovation in Prostate Diagnostics
URO-1, Inc. Aims to Advance Targeted Biopsy Technology to Support Diagnostic Precision and Pathology Workflow
URO-1 prostate biopsy devices adopted across Novant Health System as clinical study continues
Novant's use of URO-1 for prostate biopsies increasing | North Carolina Biotechnology Center
AUA 2025: A Novel Core Needle Biopsy Instrument Designed for Targeted Biopsy
The Details Are in the Core: Advancing Prostate Tissue Collection - James Wysock
From Archaic Needles to Cutting-Edge Precision: URO-1's Breakfthough in Biopsy Technology
URO-1 reaches new milestone in equity financing, clinical validation and manufacturing
Optimizing Prostate Biopsy Specimens for Improved Pathological Diagnosis - Daniel Wiener
URO-1 Reaches Milestone in Soft Tissue Biopsies to Identify Cancer
From Survivor to Innovator: Ted Belleza and the URO-1 Team's Mission to Improve Prostate Cancer Diagnosis
Innovators at work: the companies shaping a smarter, greener, and more connected world